Literature DB >> 828374

[Experments on the mechanism of action of vascular spasmolytic agents. I. Effect nitroprusside sodium, nitroglycerine, prenylamine and verapamil on the arrested potassium contracture of isolated coronary arteries].

R Fermum, U Klinner, P Meisel.   

Abstract

On the potassium contracture of isolated coronary arteries of cattle, the relaxation effected by calcium depletion can be blocked by lanthanum ions. The contracture persisting in calcium-free solution (arrested potassium contracture) is used to differentiate the sites of attack of spasmolytics. Verapamil and prenylamine are ineffective in this contracture model. By contrast, nitroprusside sodium and nitroglycerol as before act spasmolytically. Thus, both groups of drugs act through basically different sites. The findings are consistent with the hypothesis that the spasmolytic action of verapamil and prenylamine is based on a blockade of calcium influx. For nitroprusside sodium and nitroglycerol such a mechanism on the arrested potassium contracture has to be ruled out.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 828374

Source DB:  PubMed          Journal:  Acta Biol Med Ger        ISSN: 0001-5318


  3 in total

1.  Relaxation of hormonally stimulated smooth muscular tissues by the 8-bromo derivative of cyclic GMP.

Authors:  K D Schultz; E Böhme; V A Kreye; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

2.  Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle.

Authors:  W R Kukovetz; S Holzmann; A Wurm; G Pöch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

3.  On the haemodynamic differences between sodium nitroprusside, nitroglycerin, and isosorbide nitrates. Comparison of their vasorelaxant effects in vitro and of their inactivation in vivo.

Authors:  A Stiefel; V A Kreye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.